Trial Profile
Clinical utility of serum glycan in survival in patients with hepatocellular carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Pharmacodynamics; Therapeutic Use
- 17 Dec 2015 New trial record